Abaxx Announces Closing of Strategic Financing in Abaxx Singapore
10 janv. 2024 07h00 HE
|
Abaxx Technologies Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF)...
Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement
29 déc. 2023 17h00 HE
|
Blueberries Medical Corp.
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Stay Inc. Announces $5 Million USD Offering
07 déc. 2023 08h50 HE
|
Stay Inc.
STAY INC. ANNOUNCES $5 MILLION USD OFFERING
Abaxx Closes CAD$30.7 Million Financing and Terminates ATM Program
21 nov. 2023 17h25 HE
|
Abaxx Technologies Inc.
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 26, 2023 to its short form base shelf prospectus dated November 4, 2021 ...
Jo-Jo Capital Canada Ltd. Announces Closing of Initial Public Offering
14 nov. 2023 12h57 HE
|
Jo-Jo Capital Canada Ltd.
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Jo-Jo Capital Canada Ltd. (the "Corporation") (TSXV:...
OKYO Pharma Announces $5.84 Million Cash Raise and Payables Reduction
31 oct. 2023 07h00 HE
|
OKYO Pharma LTD
Pricing of a registered direct offering for $1.64M of 1,092,600 ordinary shares at an offering price of $1.50 per ordinary shareSimultaneous extinguishment of $4.20M of payables by issuing 2,766,667...
RAMM Pharma Corp. Announces Corporate Update
11 oct. 2023 11h49 HE
|
RAMM Pharma Corp.
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- On September 5th, 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
OKYO Pharma Announces Closing of $4.0 Million Registered Direct Offering of Ordinary Shares
15 sept. 2023 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
OKYO Pharma Announces Public Offering of Ordinary Shares
13 sept. 2023 16h05 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
Big Screen Entertainment Group Unveils Innovative Reg D Offering Propelling $75 Million Film Fund Launch
06 sept. 2023 10h07 HE
|
Big Screen Entertainment Group
LOS ANGELES, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Big Screen Entertainment Group (OTC: BSEG) – a thriving production and distribution company in Los Angeles – has launched an offering of its common...